These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34080549)

  • 1. Recovering from substance use disorders during the early months of the COVID-19 pandemic: A mixed-methods longitudinal study of women in Kansas City.
    Hurley EA; Piña K; Cegielski V; Noel-MacDonnell JR; Miller MK
    J Subst Abuse Treat; 2021 Oct; 129():108378. PubMed ID: 34080549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Young adults with a history of substance use disorder experienced more negative mental health, social and economic outcomes during the COVID-19 pandemic period.
    Halvorson MA; Kuklinski MR; Bailey JA; Caouette JD; Guttmannova K; Rhew IC; Oesterle S
    Addiction; 2024 Sep; 119(9):1597-1607. PubMed ID: 38923042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-related social determinants of substance use disorder among diverse U.S. racial ethnic groups.
    Tao X; Liu T; Fisher CB; Giorgi S; Curtis B
    Soc Sci Med; 2023 Jan; 317():115599. PubMed ID: 36525785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of COVID-19 Pandemic Policy on Social Needs Across the State of Kansas and Western Missouri: Paired Survey Response Testing.
    Mudaranthakam DP; Pepper S; Fortney T; Alsup A; Woodward J; Sykes K; Calhoun E
    JMIR Public Health Surveill; 2023 Apr; 9():e41369. PubMed ID: 36977199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the impact of the COVID-19 pandemic on stress, mood, and substance use among young adults in the greater Minneapolis-St. Paul area: Findings from project EAT.
    Emery RL; Johnson ST; Simone M; Loth KA; Berge JM; Neumark-Sztainer D
    Soc Sci Med; 2021 May; 276():113826. PubMed ID: 33743209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland.
    Patel EU; Grieb SM; Winiker AK; Ching J; Schluth CG; Mehta SH; Kirk GD; Genberg BL
    Harm Reduct J; 2024 May; 21(1):91. PubMed ID: 38720307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of COVID-19 on residential treatment programs for substance use disorder.
    Pagano A; Hosakote S; Kapiteni K; Straus ER; Wong J; Guydish JR
    J Subst Abuse Treat; 2021 Apr; 123():108255. PubMed ID: 33375986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences with and impacts of the COVID-19 pandemic by substance use disorder in the early phase of pandemic in the United States: A cross-sectional survey, 2020.
    Acevedo A; Feng W; Corlin L; Allen JD; Levine P; Stopka TJ
    PLoS One; 2022; 17(7):e0271788. PubMed ID: 35862354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptions of individuals in treatment for substance use disorder during COVID-19: insight on mental health, sobriety, access to treatment, and telehealth.
    Bayers T; Strohmaier T; Shreffler J; Huecker M
    J Addict Dis; 2022; 40(1):111-113. PubMed ID: 34296654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a structural vulnerability framework to understand the impact of COVID-19 on the lives of Medicaid beneficiaries receiving substance use treatment in New York City.
    Zhen-Duan J; Gade N; Falgas-Bagué I; Sue KL; DeJonckheere M; Alegría M
    Health Serv Res; 2022 Oct; 57(5):1104-1111. PubMed ID: 35340033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary findings on the experiences of care for women who suffered early pregnancy losses during the COVID-19 pandemic: a qualitative study.
    Silverio SA; George-Carey R; Memtsa M; Kent-Nye FE; Magee LA; Sheen KS; Burgess K; Oza M; Storey C; Sandall J; ; Easter A; von Dadelszen P; Jurković D
    BMC Pregnancy Childbirth; 2024 Aug; 24(1):522. PubMed ID: 39123186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gigii-Bapiimin Study: resilience and the impacts of COVID-19 on health and wellbeing of Indigenous people living with HIV in Manitoba and Saskatchewan.
    Souleymanov R; Still M; Christianson T; Morris M; Favel A; Wahpoosewyan D; McLeod A; Gervais L; King A; Piyesis MK; Jackson R; Payne M; Ringaert L; Larcombe L; Restall G; Montpetit D
    AIDS Care; 2024 Jul; 36(7):899-907. PubMed ID: 38843558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persons with Substance Abuse Disorders and Other Addictions: Coping with the COVID-19 Pandemic.
    Fabelo-Roche JR; Iglesias-Moré S; Gómez-García AM
    MEDICC Rev; 2021 Apr; 23(2):55. PubMed ID: 33974609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing clinical impacts and attitudes related to COVID-19 among residential substance use disorder patients.
    Wildberger J; Wenzel K; Fishman M
    Subst Abus; 2022; 43(1):756-762. PubMed ID: 35112980
    [No Abstract]   [Full Text] [Related]  

  • 17. "Maybe if we weren't in the pandemic, I would have reconsidered": Experiences of abortion care-seeking during the COVID-19 pandemic in Maryland.
    Dozier JL; Burke AE; McMahon HV; Berger BO; Quasebarth M; Sufrin C; Bell SO
    Perspect Sex Reprod Health; 2024 Jun; 56(2):124-135. PubMed ID: 38655782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in substance use, recovery, and quality of life during the initial phase of the COVID-19 pandemic.
    Lewandowski ME; Delawalla CN; Butcher TJ; Oberlin BG
    PLoS One; 2024; 19(5):e0300848. PubMed ID: 38776315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residential substance use treatment outcomes for pregnant and postpartum women: Distinct patterns for women enrolled before versus during the COVID-19 pandemic.
    Chou JL; Noel JG; Williams C; Spruell S; Nixon K; Riedel E; Zaarur A
    J Nurs Scholarsh; 2023 May; 55(3):730-738. PubMed ID: 35920587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID 19-impact on substance use treatment utilization and provision in South Africa.
    Harker N; Johnson K; Erasmus J; Myers B
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):15. PubMed ID: 35241095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.